Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activator

J Am Coll Cardiol. 1991 Mar 1;17(3):805-11. doi: 10.1016/s0735-1097(10)80201-3.

Abstract

Dynamic coronary vasoconstriction may play a role in coronary artery reocclusion after successful thrombolysis. The effect of nitroglycerin on the thrombolytic effects of recombinant tissue-type plasminogen activator (rt-PA) was examined in dogs with an electrically induced occlusive coronary artery thrombus. Eleven dogs were randomly given rt-PA alone and seven rt-PA with nitroglycerin. The dose of rt-PA was 0.75 mg/kg body weight given over 20 min and the dose of nitroglycerin was 125 micrograms/min for 40 min. The reperfusion rate in the dogs given rt-PA alone was 73% (8 of 11 dogs) and that in the rt-PA plus nitroglycerin group was 57% (four of seven dogs) (p = NS). The time to thrombolysis (or reperfusion) in dogs receiving rt-PA plus nitroglycerin was 70% greater than in those receiving rt-PA alone (means +/- SD/29.8 +/- 9.9 versus 17.6 +/- 5.9 min, p less than 0.02), and the duration of reperfusion much shorter (11 +/- 17 versus 42 +/- 16 min, p less than 0.02). Peak coronary blood flow after reperfusion in dogs receiving rt-PA plus nitroglycerin was also less than in those receiving rt-PA alone (36 +/- 52 versus 63 +/- 20 ml/min, p less than 0.02). Reocclusion occurred in all dogs given rt-PA with nitroglycerin and in six of eight given rt-PA alone (p = NS). Plasma concentrations of rt-PA were lower when nitroglycerin was given with rt-PA alone (427 +/- 279 versus 1,471 +/- 600 ng/ml, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Coronary Circulation / drug effects
  • Coronary Disease / drug therapy*
  • Dogs
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Hemodynamics / drug effects
  • Male
  • Myocardial Reperfusion
  • Nitroglycerin / administration & dosage
  • Nitroglycerin / pharmacology*
  • Platelet Aggregation / drug effects
  • Platelet Count / drug effects
  • Recurrence
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / antagonists & inhibitors*
  • Tissue Plasminogen Activator / blood

Substances

  • Tissue Plasminogen Activator
  • Nitroglycerin